Biomedical Engineering Reference
In-Depth Information
analysis to achieve significant increases in both sensitivity and resolution. J Mass Spectrom
43:1512-1520. doi:10.1002/jms.1428
41. Anker J, Hall W, Lambert M, Velasco P, Mrksich M, Klein W, Van Duyne R (2009) Detection
and identification of bioanalytes with high resolution LSPR spectroscopy and MALDI mass
spectrometry. J Phys Chem 113:5891-5894. doi:10.1021/jp900266k
42. Bauer J, Chakravarthy A, Rosenbluth J, Mi D, Seeley E, Granja-Ingram N, Olivares M, Kelley
M, Mayer I, Meszoely I, Means-Powell J, Johnson K, Tsai C, Ayers G, Sanders M, Schneider
R, Formenti S, Caprioli R, Pietenpol J (2010) Proteomic and genomic analyses of breast
tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res
16(2):681-690. doi:10.1158/1078-0432.CCR-09-1091
43. Benabdellah F, Touboul D, Brunelle A, Laprévote O (2009) In situ primary metabolites local-
ization on a rat brain section by chemical mass spectrometry imaging. Anal Chem 81:5557-
5560. doi:10.1021/ac9005364
44. Goodwin R, Dungworth J, Cobb S, Pitt A (2008) Time-dependent evolution of tissue markers
by MALDI-MS imaging. Proteomics 8:3801-3808. doi:10. 1002/pmic.2008002001
45. Lemaire R, Menguellet S, Stauber J, Marchaudon V, Lucot J, Collinet P, Farine M, Vinatier D,
Day R, Ducoroy P, Salzet M, Fournier I (2007) Specific MALDI imaging and profiling for
biomarker hunting and validation: fragment of the 11 S proteasome activator complex, rag
alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res 6:4127-4134.
doi:10.1021/pr0702722
46. Lemaire R, Stauber J, Wisztorski M, Van Camp C, Desmons A, Deschamps M, Proess G,
Rudlof I, Woods A, Day R, Salzet M, Fournier I (2007) Tag-mass: specific molecular imaging
of transcriptome and proteome by mass spectrometry based on photocleavable tag. J Proteome
Res 6:2057-2067. doi:10.1021/rp0700044
47. Meistermann H, Norris J, Aerni H, Cornett D, Friedlein A, Erskine A, Augustin A, Mudry M,
Ruepp S, Suter L, Langen H, Caprioli R, Ducret A (2006) Biomarker discovery by imaging
mass spectrometry, transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat.
Mol Cell Proteomics 5:1876-1886. doi:10.1074/mcp.M500399-MCP200
48. Stauber J, Lemaire R, Franck J, Bonnel D, Croix D, Day R, Wisztorski M, Fournier I, Salzet
M (2008) MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model
animals of Parkinson disease for biomarker hunting. J Proteome Res 7:969-978. doi:10.1021/
pt070464x
49. Chen J, Hsieh Y, Knemeyer I, Crossman L, Korfmacher W (2008) Visualization of first-pass
drug metabolism of terfenadine by MALDI-imaging mass spectrometry. Drug Metab Lett
2:1-4
50. Cohen L, Gusev A (2001) Small molecule analysis by MALDI mass spectrometry. Anal
Bioanal Chem 373:571-586. doi:10.1007/s00216-002-1321-z
51. Cristoni S, Brioschi M, Rizzi A, Sironi L, Gelosa P, Tremoli E, Bernardi L, Banfi C (2006)
Analysis of rosuvastatin by imaging mass spectrometry. Rapid Commun Mass Spectrom
20:3483-3487. doi:10.1002/rcm.2744
52. Hsieh Y, Casale R, Fukuda E, Chen J, Knemeyer I, Wingate J, Morrison R, Korfmacher W
(2006) Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct mea-
surement of clozapine in rat brain tissue. Rapid Commun Mass Spectrom 20:965-972.
doi:10.1002/rcm.2397
53. Mangé A, Chaurand P, Perrochia H, Roger P, Caprioli R, Solassol J (2009) Liquid chromatog-
raphy-tandem and MALDI imaging mass spectrometry analyses of RCL2/CS100-fixed,
paraffin-embedded tissue: proteomics evaluation of an alternate fixative for biomarker discov-
ery. J Proteome Res 8:5619-5628. doi:10.1021/pr9007128
54. Signor J, Varesio E, Staack R, Starke V, Richter W, Hopfgartner G (2007) Analysis of erlotinib
and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrom-
etry. J Mass Spectrom 42:900-909. doi:10.1002/jms.1225
55. Su A, Liu J, Lin C (2005) Rapid drug-screening of clandestine tablets by MALDI-TOF mass
spectrometry. Talanta 67:718-724. doi:10.1016/j.talanta.2005.03.013
